期刊文献+

托伐普坦治疗严重心力衰竭伴乙型肝炎肝硬化腹水的疗效评价 被引量:1

原文传递
导出
摘要 2006年3月至2014年12月,我科共收治临床资料较为完整的重度心力衰竭伴乙型肝炎肝硬化大量腹水的患者18例,其中有8例病人在常规治疗基础上同时加用托伐普坦治疗,与常规治疗相比,临床疗效非常显著,现报道如下。
作者 刘斌
出处 《实用老年医学》 CAS 2016年第8期697-698,共2页 Practical Geriatrics
  • 相关文献

参考文献4

二级参考文献44

  • 1赵守松.肝肾综合征的研究现状[J].实用肝脏病杂志,2006,9(1):58-61. 被引量:5
  • 2Teresa A,Martin M.Vasopressin-receptor antagonists in heart failure[J].Am J Health-Syst Pharm,2008,65(9):807-817.
  • 3Chandrashekhar Y,Prahash AJ,Sen S,et al.The role of arginine vasopressin and its receptors in the normal and failing rat heart[J].J Mol Cell Cardiol,2003,35(5):495-504.
  • 4Gheorghiade M,Niazi I,Ouyang J,et al.Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure:results from a double-blind,randomized trial[J].Circulation,2003,107(21):2690-2696.
  • 5Gheorghiade M,Gattis WA,O′Connor CM,et al.Effects of tolvaptan a vasopressin antagonist,in patients hospitalized with worsening heart failure:a randomized controlled trial[J].JAMA,2004,291(16):1963-1971.
  • 6Udelson JE,Orlandi C,O′Brien T,et al.Vasopressin receptor blockade in patients with congestive heart failure;results from a placebo-controlled,randomized study comparing the effects of tolvaptan,furosemide,and their combination[J].J Am Coll Cardiol,2002,39(suppl A):810.
  • 7Costello-Boerrigter LC,Smith WB,Boerrigter G,et al.Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure[J].Am J Physiol Renal Physiol,2006,290(2):F273-278.
  • 8Udelson JE,McGrew F,Flores E,et al.Multicenter,randomized,double-blind,placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction[J].J Am Coll Cardiol,2007,49(22):2151-2159.
  • 9Gheorghiade M,Orlandi C,Burnett JC,et al.Rationale and design of the multicenter,randomized,double-blind,placebo-controlled study to evaluate the Efficacy of Vasopressin Antagonism in Heart Failure:Outcome Study with Tolvaptan(EVEREST)[J].J Card Fail,2005,11(4):260-269.
  • 10Gheorghiade M,Konstam MA,Burnett JC Jr,et al.Short-term clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure:the EVEREST Clinical Status Trials[J].JAMA,2007,297(12):1332-1343.

共引文献35

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部